SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

Nonja is trending as community members highlight its strong performance within the Injective ecosystem and discuss its potential for significant gains, particularly with upcoming Injective upgrades and ETF possibilities. Community members emphasize Nonja's strong community, high burned liquidity, and successful NFT collections, positioning it as a leading meme coin on the Injective blockchain. Discussions also focus on its potential for high returns and its solid chart as positive factors.

this coin is scarce

SCARCE CRYPTO is trending as traders discuss its potential for a breakout, citing a tightening chart and accumulation by larger holders. The community emphasizes its low supply and is watching closely for a significant move, with some comparing it to other Solana-based tokens.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is gaining traction as the community rallies behind its vision within the Bitcoin ecosystem, particularly its role in the Rune revolution. Discussions highlight its potential to drive a Bitcoin-native culture and its commitment to a fair, community-driven approach, with some anticipating upcoming catalysts like ZAP integration.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet ($STRK) is trending as the community highlights its potential for scaling Bitcoin and Zcash, creating a "Ztarknet" for privacy and scalability. Recent upgrades and incentives for Bitcoin liquidity staking are driving interest, with some seeing it as a key player in Layer 2 solutions. Discussions also focus on the technology's potential for enabling advanced dApps and its ties to zero-knowledge proofs.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as traders explore privacy-focused cryptocurrencies, drawing comparisons to early Bitcoin due to its limited supply. The community is closely watching Cypherpunk Technologies' (CYPH) accumulation of ZEC, backed by the Winklevoss twins, and speculating on its potential impact. Discussions also highlight ZEC's role in scaling privacy at Layer-2 via Starknet.

Royal Bank of Canada engages in the provision of banking and financial services. It operates through the following segments: Personal and Commercial Banking, Wealth Management, Insurance, Capital Markets, and Corporate Support. The Personal and Commercial Banking segment deals with a broad suite of financial products and services in both individual and business clients in Canada, the Caribbean, and the U.S. The Wealth Management segment offers a suite of wealth, investment, trust, banking, credit, and other advice-based solutions. It also offers other wealth management solutions to institutional and individual clients through its distribution channels and third-party distributors. The Insurance segment refers to a suite of advice and solutions for individual and business clients including life, health, wealth, property and casualty, travel, group benefits, annuities, and reinsurance. The Capital Markets segment is involved in the provision of advisory and origination, sales and trading, lending and financing and transaction banking to corporations, institutional clients, asset managers, private equity firms and governments globally. The Corporate Support segment consists of technology and operations services. The company was founded by J. W. Merkell, Edward Kenny, T. C. Kinnear, James B. Duffus, William Cunard, John Tobin, George P. Mitchell and Jeremiah Northup in 1864 and is headquartered in Toronto, Canada.

Royal Bank Of Canada

Royal Bank of Canada ($RY) is garnering attention due to Elliott Wave analysis suggesting a potential rally continuation before a larger pullback, with some analysts eyeing specific upside targets. Community discussions revolve around identifying the peak of this bullish wave and preparing for a subsequent corrective phase. Recent data indicates resilient consumer spending and stabilization in the housing market, further influencing investor sentiment.

CommScope Holding Co., Inc. engages in the provision of infrastructure solutions for communication, data center, and entertainment networks. It operates through the following segments: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), Access Network Solutions (ANS), and Corporate and Other. The CCS segment focuses on fiber optic, copper connectivity, and cable solutions for use in telecommunications, cable television, residential broadband networks, data centers, and business enterprises. The NICS segment provides wireless networks for enterprises and service providers. The ANS segment refers to the cable modem termination systems, video infrastructure, distribution and transmission equipment, and cloud solutions that enable facility-based service providers to construct a residential and metro distribution network. The company was founded by Frank M. Drendel in 1976 and is headquartered in Richardson, TX.

CommScope Holding Company Inc

Fueled by news of a major asset sale to Amphenol, CommScope is trending as the community discusses the implications of becoming debt-free and the potential for a special dividend. Technical analysis and potential trading strategies are circulating, with some cautioning about overbought conditions while others point to a bullish outlook. Discussions also include debate around forward revenues, with varied opinions on the longer-term impact of the sale.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium (CCD) is gaining attention as a privacy-focused, regulation-friendly layer-1 blockchain, with community members highlighting its potential for real-world adoption and compliant stablecoin payments. Recent partnerships with Ledger and bitcoin.com/ are driving increased interest, as users speculate on its potential to disrupt the PayFi space. The community emphasizes CCD's focus on verifiable trust and on-chain identity, positioning it as a key infrastructure play for the future of regulated DeFi.

Aster is a next-generation decentralized exchange offering both Perpetual and Spot trading, designed as a one-stop onchain venue for global crypto traders. It features MEV-free, one-click execution in Simple Mode. Pro Mode adds 24/7 stock perpetuals, Hidden Orders, and grid trading, available across BNB Chain, Ethereum, Solana, and Arbitrum.  Its unique edge lies in the ability to offer liquid-staking tokens (asBNB) or yield-generating stablecoins (USDF) as collateral, unlocking unparalleled capital efficiency. Powered by Aster Chain, a high-performance and privacy-focused L1, and backed by YZi Labs, Aster is building the future of DeFi: fast, flexible, and community-first.  At the heart of this ecosystem is the $ASTER token, a core asset that decentralizes governance, drives growth, rewards participation, and supports long-term sustainability.

ASTERION

ASTER is trending as the crypto community discusses its resilience amid a red market and news around buybacks. Some believe the coin is primed for a run, fueled by speculation around CZ's involvement, while others are wary of potential manipulation and dilution. Community members are weighing the potential of ASTER as a decentralized exchange against concerns of centralization.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is trending as community members discuss its potential, technological advantages, and future price targets. Despite some concerns about short-term price action and exchange listings, there is optimism about upcoming smart contracts and their potential impact. The community also notes Kaspa's unique attributes, such as its fair launch and fast transaction speeds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenon Pharmaceuticals Inc. $XENE Shares Sold by Candriam S.C.A.

Candriam S.C.A. lowered its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 12.8% during the second quarter, according to its most recent disclosure with the Securities and...

Nan Fung Trinity HK Ltd. Takes $4.96 Million Position in Xenon Pharmaceuticals Inc. $XENE

Nan Fung Trinity HK Ltd. bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the second quarter, according to the company in its most recent disclosure with the...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen research firms that are covering the firm, MarketBeat reports. One analyst...

FY2029 EPS Estimate for Xenon Pharmaceuticals Cut by Analyst

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) - Equities researchers at Wedbush cut their FY2029 earnings per share (EPS) estimates for Xenon Pharmaceuticals in a report issued on Tuesday...

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

XENE reports narrower-than-expected Q3 loss as the biotech advances multiple late-stage studies of azetukalner across epilepsy and mood disorders.

Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?

Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus

XENE's wider Q2 loss highlights its push toward late-stage epilepsy, depression, and bipolar disorder studies with azetukalner.

Biogen shares slipped on Monday after the company said it expects to take a $46 million charge in the second quarter related to R&amp;D deals and milestone payments.&nbsp;The expense is set to shave&nbsp;off about $0.26 off its per-share earnings, both on a GAAP and adjusted basis.The update adds to investor caution following the FDA’s recent signal report published on June 30, which named Biogen’s Alzheimer’s treatment Leqembi as one of several drugs flagged for potential post-marketing safety concerns.&nbsp;The report, compiled from the FDA’s FAERS database, represents a push for increased transparency around adverse event reporting.Analysts at RBC Capital said they do not anticipate major regulatory fallout, noting that the data was already publicly available and the risks broadly acknowledged.&nbsp;However, they said the FDA’s move could still create some sentiment overhang for Biogen and other named firms, including Sarepta, Alkermes, Biohaven, Xenon, and Argenx.<a href="https://stocktwits.com/symbol/BIIB">Biogen’s</a> newly itemized R&amp;D charges follow its Q1 decision to present such costs as a separate line item on its income statement.&nbsp;The company stated that these typically include expenses from licensing deals and asset acquisitions, which are accounted for as in-process research and development.Meanwhile, Biogen is advancing its drug pipeline, beginning a Phase 3 study with felzartamab, which can treat a kidney condition known as primary membranous nephropathy.The trial, dubbed Prominent, began dosing patients late last month and will enroll about 180 adults.On Stocktwits, retail sentiment for Biogen was ‘bullish’ amid ‘low’ message volume.Biogen’s stock has declined 13.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the logo of Biogen is seen on a smartphone with the FDA logo in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)  

Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit

The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share.

Equity

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Xenon Pharmaceuticals Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

XENE
Xenon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest XENE News

XENEXenon Pharmaceuticals Inc